The United States continues to play a critical role in clinical research and healthcare technology adoption. The presence of major pharmaceutical companies, biotechnology innovators, research institutions, and technology providers contributes significantly to software adoption. Growing investments in digital health solutions, artificial intelligence, and remote patient monitoring platforms...

The eClinical solutions market is becoming an increasingly important part of modern clinical research as pharmaceutical and biotechnology companies manage larger datasets, more complex protocols, decentralized trials, and stricter regulatory requirements. The market was valued at USD 11.5 billion in 2025 and is projected to grow from USD 13.1 billion in 2026 to USD 35.1 billion by 2033,...

Clinical trials are becoming increasingly complex, creating stronger demand for technologies capable of managing patient randomization, treatment allocation, drug supply, and operational coordination. Against this backdrop, the randomization and trial supply management (RTSM) market is gaining momentum as sponsors, contract research organizations (CROs), and other clinical research stakeholders...